Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:38 p.m.

    📋 VANDA PHARMACEUTICALS INC. (VNDA) - Financial Results

    Filing Date: 2022-08-03

    Accepted: 2022-08-03 16:12:04

    Event Type: Financial Results

    Event Details:

    Vanda Pharmaceuticals Inc (VNDA) Reports Q3 2022 Financial Results Vanda Pharmaceuticals Inc (VNDA) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 38164
    • Net Income: 0.05
    • EPS: Not disclosed
    • Cash and equivalents: 58226
      • expected in the coming quarters, and we are preparing our NDA for tradipitant in gastroparesis and our sNDA for HETLIOZ® in insomnia.”Financial HighlightsSecond Quarter of 2022
      • expected by the end of 2022
      • anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Forward-looking statements in this press release should be evaluated together with the various risks and uncertainties that affect Vanda’s business and market, particularly those identified in the “Cautionary Note Regarding Forward-Looking Statements”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Vanda’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Selling General Administrative 28.35K 73.85K $-45.50K -61.61%
    Current Assets Prepaid Expenses Other Current Assets 25.74K 12.00K $13.74K +114.54%
    Current Assets Property Equipment Net 2.75K 3.11K $-367.00 -11.79%
    Current Assets Operating Lease Right Of Use Assets 8.60K 9.27K $-669.00 -7.22%
    Current Assets Intangible Assets Net 19.32K 20.08K $-758.00 -3.77%
    Revenue 64.39K 67.90K $-3.51K -5.17%
    Selling, General & Administrative 33.00K 28.35K $4.65K +16.42%
    Loss from Operations 3.46K 12.37K $-8.91K -72.02%
    Prepaid Expenses and Other Current Assets 25.74K 12.00K $13.74K +114.54%
    Property and Equipment, Net 2.75K 3.11K $-367.00 -11.79%
    Intangible Assets, Net 19.32K 20.08K $-758.00 -3.77%
    Accounts Payable 50.24K 50.24K $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Vanda Pharmaceuticals Inc
    • CIK: 0001347178
    • Ticker Symbol: VNDA
    • Period End Date: 2022-08-03
    • Document Type: 8-K

Search

News categories